A Novel Injection Technique to Prevent Exacerbation of Sunken Cheek After Botulinum Toxin Type A Treatment for Masseter Hypertrophy: A Prospective Clinical Study
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Shi-Liu Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Aesthetic Medicine, Xi'an Honghui Hospital, Xi'an, China. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Masseter Muscle, Hypertrophy, Cheek. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives Sunken cheek is often an undesirable aesthetic outcome, making the face appear gaunt and tired. It is also a common adverse effect of injections for treating masseter hypertrophy. This study aims to assess the efficacy of a novel injection technique in preventing sunken cheek after botulinum toxin type A (BoNT‐A) treatment for masseter hypertrophy, focusing on minimizing adverse aesthetic effects while ensuring effective masseter muscle reduction. Materials and Methods The degree of sunken cheek was compared on both sides before injection and 4 weeks postinjection using the validated assessment scales for the midface by Jean Carruthers, etc. Telephone follow‐ups were conducted in weeks 1, 2, and 4 to assess subjective perceptions of sunken cheek, monitor adverse effects, and evaluate participant satisfaction with the procedure and the hospital.
Results
Before treatment, there were nine participants with Grade 0, 62 with Grade 1, and 11 with Grade 2 sunken cheek. At week 4, the numbers were 13 with Grade 0, 59 with Grade 1, and 10 with Grade 2. No patients reported an aggravation of sunken cheek during follow‐up calls. Adverse reactions primarily occurred within the first 2 weeks and improved spontaneously.
Conclusions
The novel BoNT‐A injection technique for masseter hypertrophy is safe and prevents the exacerbation of sunken cheeks. The results suggest that this method does not aggravate sunken cheeks and may even improve cheek depression severity in some individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Aesthetic Medicine, Xi'an Honghui Hospital, Xi'an, China.
- Department of Medical Cosmetology, Xi'an Jiaotong University College of Stomatology, Xi'an, China.
- Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Dermatology, Xi'an People's Hospital, Xi'an, China.
- Department of Medicine, Xi'an Jiaotong University College of Stomatology, Xi'an, China.
ORCID-Profile: Shi-Liu Huang
Zitieren
APA
Huang, S. L., Guo, Y., Liu, J., Ye, D., Wang, Z. Y., Gao, H. Y., & Dong, Y. L. (2025). A Novel Injection Technique to Prevent Exacerbation of Sunken Cheek After Botulinum Toxin Type A Treatment for Masseter Hypertrophy: A Prospective Clinical Study. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70120
Vancouver
Huang SL, Guo Y, Liu J, Ye D, Wang ZY, Gao HY, et al. A Novel Injection Technique to Prevent Exacerbation of Sunken Cheek After Botulinum Toxin Type A Treatment for Masseter Hypertrophy: A Prospective Clinical Study. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70120
BibTeX
@article{Huang2025,
author = {Huang, Shi-Liu and Guo, Yan and Liu, Jing and Ye, Dan and Wang, Zhao-Yang and Gao, Hong-Yan and Dong, Yu-Lin},
title = {A Novel Injection Technique to Prevent Exacerbation of Sunken Cheek After Botulinum Toxin Type A Treatment for Masseter Hypertrophy: A Prospective Clinical Study},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70120}
}
EUVIMED